Afshin Mahmoudi

Crystal Structures of PRK1 in Complex with the Clinical Compounds Lestaurtinib and Tofacitinib Reveal Ligand Induced Conformational Changes

B. Cathers, M. Abbasian, B. Pagarigan, 2014, PloS one.

Cereblon is a direct protein target for immunomodulatory and antiproliferative activities of lenalidomide and pomalidomide

S. Karasawa, H. Handa, A. Lopez-Girona, 2012, Leukemia.

Protein Degradation via CRL4CRBN Ubiquitin Ligase: Discovery and Structure-Activity Relationships of Novel Glutarimide Analogs That Promote Degradation of Aiolos and/or GSPT1.

Chin-Chun Lu, L. LeBrun, Alexander L. Ruchelman, 2017, Journal of medicinal chemistry.

Measuring cereblon as a biomarker of response or resistance to lenalidomide and pomalidomide requires use of standardized reagents and understanding of gene complexity

R. Chopra, B. Cathers, P. Schafer, 2013, British journal of haematology.